| Literature DB >> 2642312 |
R G Gagliano1, B A Blumenstein, E D Crawford, R L Stephens, C A Coltman, J J Costanzi.
Abstract
A total of 26 patients with biopsy proved epidermoid carcinoma of the penis (Jackson stage III or IV) with measurable disease, no prior chemotherapy and adequate renal function received 50 mg. per M.2 cis-diamminedichloroplatinum intravenously on days 1 and 8 of 28-day cycles. There were 4 partial responses (15.4 per cent), with a response duration of 1 to 3 months. The median survival was 4.7 months. This agent cannot be recommended as treatment for advanced epidermoid carcinoma of the penis using this particular dose and schedule.Entities:
Mesh：
Substances：
Year: 1989 PMID： 2642312 DOI： 10.1016/s0022-5347(17)40590-8
Source DB: PubMed Journal: J Urol ISSN： 0022-5347 Impact factor: 7.450